Sofinnova Ventures, Inc.

Sofinnova Ventures, Inc.

Sofinnova Ventures, Inc.

Overview
Date Founded

1974

Headquarters

3000 Sand Hill Road,Building 4,Suite 250,Menlo Park, CA 94025-7113

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Private Equity & Venture Capital
Hospitals & Patient Services
Biotechnology
Investment Services & Portfolio Management

Company Description

Sofinnova is a clinical-stage biopharmaceutical venture capital firm focused on life science and information technology. They specializes in clinical and late preclinical investments in biopharmaceutical products and partner with entrepreneurs across all stages of company formation including securing initial funding, building successful management teams, forming impactful corporate alliances, and navigating the M&A acquisition or IPOs' process. Sofinnova invests in companies in the US and Europe that do business in the US, Israel, India, China, Japan and Europe.

In The News
Subscribe now to see full news coverage
Executives & Employees

Founding Partner

President

Partner & General Counsel

Executive Partner, Private Equity

Executive Partner, Private Equity

Executive Partner, Private Equity

General Partner

General Partner

Venture Partner

Subscribe now to see full list of current and former executives
Board of Directors

Chief Financial Officer at Sofinnova Ventures, Inc.

President at Sofinnova Ventures, Inc.

Founding Partner at Sofinnova Ventures, Inc.

General Partner at Sofinnova Ventures, Inc.

Subscribe now to see full list of current and former board members
Paths to Sofinnova Ventures, Inc.
Potential Connections via
Relationship Science
You
Sofinnova Ventures, Inc.
Recent Transactions
Details Hidden

Thomson-CSF purchases Guavus, Inc. from Intel Capital Corp., Patricia Industries, Inc., Sofinnova Ventures, Inc., Questmark Management Co. LLC, Artiman Ventures

Details Hidden

Suzhou Chunxing Precision Mechanical Co., Ltd. purchases CALIENT Technologies, Inc. from Sofinnova Ventures, Inc., TeleSoft Partners, Cayuga Management Group LLC, SDL Ventures LLC, Intuitive Venture Partners LLC

Details Hidden

Sofinnova Ventures, Inc., Sofinnova Partners SAS, ObsEva SA, Merck Ventures purchase Shandy Media, Inc.

Subscribe now to see full list of recent transations
Transaction Advisors
Escrow Agent

Advised onTargacept, Inc. purchases Catalyst Bioscience, Inc. (Inactive) from Sofinnova Ventures, Inc., Burrill & Co. LLC, Johnson & Johnson Innovation, HealthCare Ventures LLC, Rosetta Capital Ltd., Morgenthaler Management Corp.

Escrow Agent

Advised onInphi Corp. purchases Cortina Systems, Inc. from INVESCO Private Capital, Inc., Alloy Ventures, Inc., Canaan Management, Inc., Institutional Venture Partners, Sofinnova Ventures, Inc., Redpoint Ventures, Intel Capital Corp., Kodiak Venture Partners, Doll Capital Management, Inc., Icon Ventures LLC, EDV Management Co., Hotung Capital Management, Inc., Morgenthaler Management Corp., Bridgescale LLC, Vedanta Capital LLC

Subscribe now to see transaction advisors for over 2.5 million organizations
Subscribe now to see transaction advisors for over 2.5 million organizations
Advisors & Consultants
Auditor

PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY.

Custodian

Part of Bank of America Corp., Merrill Lynch, Pierce, Fenner & Smith, Inc. (San Francisco) is an American company. The firm provides brokerage and investment banking services.

Subscribe now to see advisors & consultants for over 2.5 million organizations
Legal Advisor

Founding Partner at Wilson Sonsini Goodrich & Rosati PC

Subscribe now to see advisors & consultants for over 2.5 million organizations
Investments
Details Hidden

Galera Therapeutics, Inc. develops drugs targeting oxygen metabolic pathways in cancer, fibrosis and other human diseases. Its compounds are small molecule dismutase mimetics which closely mimic the activity of the human superoxide dismutase enzymes. The firm focuses its development on the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis and cancer. The company was founded by Robert A. Beardsley, Randy W. Weiss and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.

Details Hidden

Dauntless Pharmaceuticals, Inc. develops specialty therapeutics via a one-asset, one-company model that is structured to facilitate operational efficiencies. The company was founded by Joel F. Martin and Michael F. Powell in May 2015 and is headquartered in San Diego, CA.

Details Hidden

Durata Therapeutics is developing dalbavancin, an intravenous antibiotic product candidate, for the treatment of patients with acute bacterial skin and skin structure infections, or ABSSSI, caused by Gram-positive bacteria, such as S. aureus, including Methicillin-Resistant and multi-drug resistant strains, and certain streptococcal species. Dalbavancin is a second generation, semi-synthetic lipoglycopeptide designed and under investigation for once-weekly intravenous dosing which may facilitate the treatment of patients with ABSSSI in both the in-patient and out-patient settings, reducing the length of a patient’s hospital stay or avoiding hospital admission altogether and, ultimately, lowering the overall cost of care for these patients.

Subscribe now to see full investment details